# The Impact of Omega-3 Supplementation on Gene Expression in Type 2 Diabetics

> **NCT01478776** · PHASE4 · UNKNOWN · sponsor: **Tehran University of Medical Sciences** · enrollment: 20 (estimated)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DIETARY_SUPPLEMENT:** omega-3
- **DIETARY_SUPPLEMENT:** placebo

## Key facts

- **NCT ID:** NCT01478776
- **Lead sponsor:** Tehran University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-12
- **Primary completion:** 2013-03
- **Final completion:** 2013-09
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2012-12-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01478776

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01478776, "The Impact of Omega-3 Supplementation on Gene Expression in Type 2 Diabetics". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT01478776. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*